Status:
UNKNOWN
First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
Lead Sponsor:
Medical University of Vienna
Conditions:
Cutaneous Neurofibromas
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether multiple cutaneous neurofibromas in patients with neurofibromatosis type 1 can be removed with an erbium-YAG-laser.
Detailed Description
With a prevalence of 1 in 3-5000 births, neurofibromatosis Type I is one of the most common genetic defects. The mode of inheritance is autosomal dominant and affects a gene (NF1), which is responsibl...
Eligibility Criteria
Inclusion
- Patients with multiple cutaneous neurofibromas with the request for tumor removal
Exclusion
- Pregnancy
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00921037
Start Date
April 1 2006
End Date
November 1 2012
Last Update
July 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Plastic and Reconstructive Surgery, Surgical Clinic, Medical University of Vienna
Vienna, Vienna, Austria, 1090